Role of Extracellular Vesicles on Cancer Lymphangiogenesis and Lymph Node Metastasis.

cancer exosomes extracellular vesicles (EVs) lymph node metastasis (LNM). lymphangiogenesis

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2021
Historique:
received: 07 06 2021
accepted: 20 08 2021
entrez: 23 9 2021
pubmed: 24 9 2021
medline: 24 9 2021
Statut: epublish

Résumé

Lymph node metastasis (LNM) of tumors is an established indicator of poor prognosis in patients. Tumor-associated lymphangiogenesis is a key step in LNM and has gained much attention. However, currently, there is no anti-tumor lymphangiogenesis drug used in clinical practice. Recently, studies on extracellular vesicles (EVs) have shown that different types of cells in the tumor microenvironment can release EVs that encapsulate a variety of molecules, including proteins, nucleic acids, and metabolites. Lymph endothelial cells (LECs) regulate tumor lymphangiogenesis through the uptake of EVs packed with different biologically active contents. In this review, we will discuss the possible mechanisms by which EVs participate in the regulation of tumor-associated lymphangiogenesis and LNM, summarize the potential value of EVs that can be used as biomarkers for the determination of tumor LNM, and indicate the potential anti-tumor lymphangiogenesis therapy.

Identifiants

pubmed: 34552874
doi: 10.3389/fonc.2021.721785
pmc: PMC8451414
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

721785

Informations de copyright

Copyright © 2021 Wang, Li and Zhu.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Cell Biochem. 2019 Oct;120(10):17699-17708
pubmed: 31127654
Int J Cancer. 2019 Jun 1;144(11):2795-2810
pubmed: 30485433
Aging (Albany NY). 2021 May 23;13(10):13846-13858
pubmed: 34024769
Nature. 2015 Nov 19;527(7578):329-35
pubmed: 26524530
Cancer Cell. 2005 Feb;7(2):121-7
pubmed: 15710325
Immunol Rev. 1997 Apr;156:25-37
pubmed: 9176697
J Clin Invest. 2018 Feb 1;128(2):861-875
pubmed: 29355840
Oncogene. 2015 Sep 10;34(37):4867-78
pubmed: 25500542
Cancer Res. 2004 Jun 1;64(11):4010-7
pubmed: 15173015
J Cancer. 2020 Jan 1;11(1):241-250
pubmed: 31892990
Nat Cell Biol. 2015 Jun;17(6):816-26
pubmed: 25985394
Onco Targets Ther. 2020 Feb 13;13:1311-1319
pubmed: 32103998
J Clin Invest. 2014 Mar;124(3):922-8
pubmed: 24590277
Proc Natl Acad Sci U S A. 2020 Oct 13;117(41):25859-25868
pubmed: 33004630
J Cell Physiol. 2008 Aug;216(2):347-54
pubmed: 18481261
Exp Biol Med (Maywood). 2021 Jun 18;:15353702211021022
pubmed: 34139872
Nucleic Acids Res. 2019 Jan 8;47(D1):D516-D519
pubmed: 30395310
Oncogene. 2007 Jul 12;26(32):4679-88
pubmed: 17297455
Int J Cancer. 2008 Jun 1;122(11):2471-81
pubmed: 18338756
Nat Med. 2001 Feb;7(2):192-8
pubmed: 11175850
Cancer Res. 2016 Apr 1;76(7):1770-80
pubmed: 26992424
J Extracell Vesicles. 2020 Apr 04;9(1):1746529
pubmed: 32341770
Cancer Res. 2001 Mar 1;61(5):1786-90
pubmed: 11280723
Cancers (Basel). 2021 Feb 16;13(4):
pubmed: 33669294
Int J Cancer. 2019 Sep 15;145(6):1648-1659
pubmed: 30734278
Cancer Cell. 2016 Aug 8;30(2):324-336
pubmed: 27424807
Cancer Res. 2009 Jan 1;69(1):349-57
pubmed: 19118020
Cell Death Differ. 2021 Feb;28(2):715-729
pubmed: 32929219
Biomed Res Int. 2014;2014:639058
pubmed: 25254213
Cell. 1983 Jul;33(3):967-78
pubmed: 6307529
Nat Rev Clin Oncol. 2018 Oct;15(10):617-638
pubmed: 29795272
Br J Haematol. 1967 May;13(3):269-88
pubmed: 6025241
Semin Cancer Biol. 2011 Apr;21(2):139-46
pubmed: 21251983
Semin Cell Dev Biol. 2015 Feb;38:98-105
pubmed: 25620792
Clin Transl Med. 2021 May;11(5):e425
pubmed: 34047469
Oncotarget. 2016 Jul 26;7(30):47536-47555
pubmed: 27286457
J Clin Oncol. 2007 Sep 20;25(27):4298-307
pubmed: 17878481
Int Neurourol J. 2018 Sep;22(3):220-224
pubmed: 30286586
Oncotarget. 2015 Jul 20;6(20):18081-93
pubmed: 26098776
Nat Rev Cancer. 2014 Mar;14(3):159-72
pubmed: 24561443
Clin Cancer Res. 2018 Feb 15;24(4):896-905
pubmed: 29233903
Nat Commun. 2018 Sep 20;9(1):3826
pubmed: 30237493
Oncogene. 2019 Feb;38(8):1256-1268
pubmed: 30254211
Nat Rev Cancer. 2005 Sep;5(9):735-43
pubmed: 16079909
Clin Transl Med. 2021 Jul;11(7):e497
pubmed: 34323412
J Mol Med (Berl). 2015 Nov;93(11):1173-84
pubmed: 26489604
J Cancer. 2020 Apr 6;11(14):4037-4046
pubmed: 32368286
Cell Death Dis. 2017 Aug 3;8(8):e2964
pubmed: 28771226
Nat Rev Clin Oncol. 2017 Mar;14(3):155-167
pubmed: 27644321
Oncotarget. 2016 Mar 29;7(13):16070-89
pubmed: 26893367
Cancer Cell. 2016 Dec 12;30(6):836-848
pubmed: 27960084
Cancer Biol Med. 2020 Aug 15;17(3):753-767
pubmed: 32944404
Mol Ther. 2021 Apr 7;29(4):1512-1528
pubmed: 33388421
Mol Cancer. 2019 Mar 30;18(1):59
pubmed: 30925927
Curr Opin Immunol. 2018 Aug;53:58-63
pubmed: 29680577
PLoS One. 2017 Oct 24;12(10):e0186718
pubmed: 29065177
Annu Rev Biochem. 2019 Jun 20;88:487-514
pubmed: 31220978
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
Gastric Cancer. 2016 Jul;19(3):754-66
pubmed: 26233326
Cancer Lett. 2015 Feb 28;357(2):438-47
pubmed: 25497008
Nat Med. 2012 Jun;18(6):883-91
pubmed: 22635005
J Cell Biol. 1969 Apr;41(1):59-72
pubmed: 5775794
J Ultrastruct Res. 1967 Sep;20(1):33-50
pubmed: 4195919
Int J Cancer. 2019 Apr 1;144(7):1486-1495
pubmed: 30155891
Cancer Sci. 2016 Apr;107(4):385-90
pubmed: 26797692
Cancer Res. 2011 Jun 1;71(11):3792-801
pubmed: 21478294
J Exp Med. 1996 Mar 1;183(3):1161-72
pubmed: 8642258
Gene. 2018 Nov 15;676:101-109
pubmed: 30010038
Cell Physiol Biochem. 2018;49(1):160-171
pubmed: 30134228
J Exp Med. 2005 Apr 4;201(7):1089-99
pubmed: 15809353
J Clin Invest. 2020 Jan 2;130(1):404-421
pubmed: 31593555
Nature. 2001 Mar 1;410(6824):50-6
pubmed: 11242036
J Mol Biol. 2016 Feb 22;428(4):688-692
pubmed: 26434508
Semin Cell Dev Biol. 2015 Apr;40:4-7
pubmed: 25704310
Am J Pathol. 2003 Jun;162(6):1951-60
pubmed: 12759251
Science. 2016 Apr 8;352(6282):242-6
pubmed: 26989197
Nat Commun. 2017 Nov 6;8(1):1319
pubmed: 29105655

Auteurs

Linlin Wang (L)

Department of Stomatology, Sichuan Cancer Hospital, Sichuan Key Laboratory of Radiation Oncology, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.

Ling Li (L)

Department of Stomatology, Sichuan Cancer Hospital, Sichuan Key Laboratory of Radiation Oncology, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.

Guiquan Zhu (G)

State Key Laboratory of Oral Diseases, National Clinical Research Centre for Oral Diseases, Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, Chengdu, China.

Classifications MeSH